Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.30% shed 0.60% to $167.97 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.15% falling 0.20% to 4,343.54 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% falling 0.60% to 34,577.37. The stock's fall snapped a four-day winning streak. Johnson & Johnson closed $5.68 below its 52-week high ($173.65), which the company achieved on January 26th.
Despite its losses, the stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -0.80% fell 2.58% to $370.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.77% fell 0.62% to $78.11, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.57% fell 1.11% to $39.29.true Trading volume (6.1 M) remained 513,199 below its 50-day average volume of 6.6 M.